Summary
Bristol-Myers Squibb Company (BMY) has filed an 8-K report detailing the upcoming departure of a key board member. Secretary Togo D. West, Jr., who has served on the Board of Directors, has informed the company that he will not seek re-election at the upcoming 2017 Annual Meeting of Shareholders, scheduled for May 2, 2017. This announcement, made on March 17, 2017, signifies a change in the composition of the company's governing body.
Key Highlights
- 1Secretary Togo D. West, Jr. will not stand for re-election to the Board of Directors.
- 2Mr. West's departure is effective at the 2017 Annual Meeting of Shareholders.
- 3The 2017 Annual Meeting of Shareholders is scheduled for May 2, 2017.
- 4This filing is an 8-K Current Report, indicating a material event.
- 5The departure relates to a director and not an executive officer, based on the filing's Item 5.02(b).
Frequently Asked Questions
Secretary Togo D. West, Jr. has notified the company that he will not stand for re-election at the upcoming 2017 Annual Meeting of Shareholders. The specific reasons for his decision are not detailed in this filing.
His departure will be effective upon the conclusion of the 2017 Annual Meeting of Shareholders, which is expected to be held on May 2, 2017.
Based on the filing (Item 5.02(b)), this pertains to the departure of a director from the Board of Directors and not an executive officer of the company.